1. Home
  2. BNR vs KORE Comparison

BNR vs KORE Comparison

Compare BNR & KORE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Burning Rock Biotech Limited

BNR

Burning Rock Biotech Limited

HOLD

Current Price

$9.67

Market Cap

76.5M

Sector

Health Care

ML Signal

HOLD

Logo KORE Group Holdings Inc.

KORE

KORE Group Holdings Inc.

HOLD

Current Price

$9.23

Market Cap

89.6M

ML Signal

HOLD

Company Overview

Basic Information
Metric
BNR
KORE
Founded
2014
2003
Country
China
United States
Employees
N/A
539
Industry
Medical Specialities
Telecommunications Equipment
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
76.5M
89.6M
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
BNR
KORE
Price
$9.67
$9.23
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
$5.00
AVG Volume (30 Days)
20.8K
78.0K
Earning Date
06-05-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$111.65
$8.96
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.51
$2.00
52 Week High
$41.72
$9.79

Technical Indicators

Market Signals
Indicator
BNR
KORE
Relative Strength Index (RSI) 49.24 50.27
Support Level $8.05 $9.11
Resistance Level $9.90 $9.79
Average True Range (ATR) 0.82 0.09
MACD 0.52 -0.01
Stochastic Oscillator 84.46 18.98

Price Performance

Historical Comparison
BNR
KORE

About BNR Burning Rock Biotech Limited

Burning Rock Biotech Ltd is a cancer diagnostics company. The Group provides pharma research and development services, mainly cancer therapy selection tests services, companion diagnostics development services, and other service agreements with the combination of various customized tests services and analytical validation services, to pharmaceutical companies for developing new drugs for targeted therapies, immunotherapies on various types of cancers, and to hospitals for their studies on cancer diagnosis & treatment. It had three operating segments, including the Central laboratory business, the In-hospital business, & Pharma research & development services. It generates the majority of its revenue from the Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, & others.

About KORE KORE Group Holdings Inc.

Kore Group Holdings Inc provides Internet of Things (IoT) solutions and services. In addition to providing critical services to customers globally, it enables them to manage, deploy, and scale their IoT applications and use cases. It offers connectivity services, location-based services, device solutions, and managed and professional services for the development and support of IoT technology for the Machine-to-Machine market. It derives revenue from IoT Connectivity services, IoT Solutions services, SIMs (IoT Connectivity), and IoT devices (IoT Solutions). Geographically, the company generates the majority of its revenue from the United States and the rest from other countries.

Share on Social Networks: